Runnymede Capital Advisors’s Sanofi SNY Stock Holding History

Runnymede Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,632	Closed	-$758K	–	115
2025 Q4	$758K	Buy	+15,632	New	+$775K	0.44%	62

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Runnymede Capital Advisors's SNY Position: Q1 2026 in Review

Runnymede Capital Advisors sold out of Sanofi (SNY) in Q1 2026, closing a stake of 15,632 shares — an estimated $758K sold.

Runnymede Capital Advisors first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $758K in Q4 2025. 747 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Runnymede Capital Advisors reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Runnymede Capital Advisors sold 15,632 Sanofi shares in Q1 2026, an estimated $758K.
Runnymede Capital Advisors first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
Runnymede Capital Advisors's Sanofi position peaked at $758K in Q4 2025.
747 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Runnymede Capital Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.